Lupkynis 7,9 mg, Weichkapsel

7680686970014 CH-68697 Kapseln
Lupkynis 7,9 mg, Weichkapsel
Lupkynis 7,9 mg, Weichkapsel
Lupkynis 7,9 mg, Weichkapsel
1 / 3
google

Article details

Package size
180
Selling units
180
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/04/2025
Patient information leaflet
Français
17/04/2025
Patient information leaflet
Italien
17/04/2025
Summary of Product Characteristics
Allemand
17/04/2025
Summary of Product Characteristics
Français
17/04/2025
Summary of Product Characteristics
Italien
17/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
7.9 MG Substance Wirkstoff (Principe actif)
(N/A)
21.57 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
28.675 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FNIDK

Reimbursement information

Public price
CHF 770.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2024

Authorization holder

Otsuka Pharmaceutical

8152 Opfikon

Authorization information

Swissmedic authorization number
68697
Drug name
Lupkynis, Weichkapsel
Galenic form
KAPWE
ATC Code
L04AD03
Authorization status
Z
Dispensing category
B
First authorization
24/04/2023
Authorization expiration date
23/04/2028
IT Number
07.15.0.
Domain
Human medicine
Field of application
Lupusnephritis der Klassen III, IV oder V bei Erwachsenen

Package details

Description (FR)
LUPKYNIS caps moll 7.9 mg 180 pce
Description (DE)
LUPKYNIS Weichkaps 7.9 mg 180 Stk
Market launch
25/04/2023
Narcotic (BTM)
No